• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Exelixis, Inc. (EXEL)

    -NasdaqGS
    2.54 Up 0.05(2.01%) Mar 27, 4:00PM EDT
    |After Hours : 2.54 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Prev Close:2.49
    Open:2.49
    Bid:2.50 x 1000
    Ask:N/A
    1y Target Est:2.50
    Beta:1.56
    Next Earnings Date:29-Apr-15EXEL Earnings announcement
    Day's Range:2.47 - 2.55
    52wk Range:1.26 - 4.55
    Volume:1,983,226
    Avg Vol (3m):3,923,400
    Market Cap:497.57M
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    EXELUp 2.01%497.57M
    AZNUp 0.43%88.51B
    GSKUp 0.77%113.11B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.86
    Quarterly EPS Est (Mar-15) :-0.25
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):0.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Exelixis, Inc., a biopharmaceutical company, develops and sells small molecule therapies for the treatment of cancer in the United States. The company offers COMETRIQ, an inhibitor of multiple receptor tyrosine kinases for the treatment of patient... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback